biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Attralus buys in brain shuttle tech to cross BBB

<< Previous

Bullboard Posts

Next >>

Post by LOOPA441on Nov 23, 2022 11:20am

185 Views

Post# 35122012

Attralus buys in brain shuttle tech to cross BBB

Attralus makes deal with Ossianix (a BBB competitor).

https://www.globenewswire.com/news-release/2022/11/17/2558010/0/en/Attralus-and-Ossianix-Announce-an-Option-and-License-Agreement-using-the-TXP1-Brain-Shuttle-for-Targeted-Delivery-of-AT-04-a-Pan-Amyloid-Removal-Therapeutic-for-Neurodegenerative-D.html

LFG!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario